rizatriptan benzoate
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Migraine With or Without Aura in Adolescents
Conditions
Acute Migraine With or Without Aura in Adolescents
Trial Timeline
Dec 1, 2009 → Apr 18, 2011
NCT ID
NCT01004263About rizatriptan benzoate
rizatriptan benzoate is a phase 3 stage product being developed by Organon for Acute Migraine With or Without Aura in Adolescents. The current trial status is completed. This product is registered under clinical trial identifier NCT01004263. Target conditions include Acute Migraine With or Without Aura in Adolescents.
What happened to similar drugs?
20 of 20 similar drugs in Acute Migraine With or Without Aura in Adolescents were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01004263 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Migraine With or Without Aura in Adolescents